Episodes
Friday Sep 02, 2022
Treating mild hypertension during pregnancy: Time for a new CHAPter!
Friday Sep 02, 2022
Friday Sep 02, 2022
Most practitioners won’t hesitate to start drug therapy in an adult patient with chronically elevated blood pressure (BP) … except, perhaps, if the patient is pregnant. In this vulnerable population, we frequently take a “wait-and-see” approach and withhold therapy unless the BP elevations become severe. But is this the right decision?
Guest Authors: Timothy D. Gladwell, PharmD, BCPS, BCACP and Scott Baker, PharmD, BCPS
Music by Good Talk
Friday Mar 19, 2021
Metformin During Pregnancy: Are the Results MiTy Enough to Change Practice?
Friday Mar 19, 2021
Friday Mar 19, 2021
The American Diabetes Association (ADA) currently recommends insulin as the preferred agent for the management of type 2 diabetes mellitus during pregnancy. However, metformin is routinely used as it has several advantages over insulin including the lower cost, less maternal weight gain, and less maternal hypoglycemia. The MiTy study explores the benefits and risks of a combination of metformin plus insulin.
Guest Authors: Hugh Quinn, PharmD and Mallory Telese, PharmD
Guest Panelists: Erin Raney, PharmD, BCPS, BC-ADM and Rebecca Stone, PharmD, BCPS, BCACP
Music by Good Talk
Friday Jan 08, 2016
Preventing Gestational Diabetes with Myo-Inositol: Ready for Prime Time?
Friday Jan 08, 2016
Friday Jan 08, 2016
With increased emphasis on disease prevention, gestational diabetes (GDM) is worthy of more attention. The incidence is on the rise not only in the United States (U.S.) but worldwide. Complications of GDM such as preeclampsia, cesarean delivery, neonatal hypoglycemia, macrosomia, and birth trauma negatively impact maternal and fetal health. Is a readily available, non-prescription dietary supplement the answer? Recent investigations have examined the use of myo-inositol for GDM prevention, with positive results.